Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Urinary Tract Infections 2Urinary Bladder Neoplasms 1Rectal Neoplasms 1Diverticulosis, Colonic 1Colonic Neoplasms 1

Interventions

Cyclophosphamide 3155Cisplatin 3151Carboplatin 2929Paclitaxel 2671Radiotherapy 2643Gemcitabine 2544pembrolizumab 2324Docetaxel 2154Bevacizumab 2126Fluorouracil 1819Capecitabine 1780Oxaliplatin 1709Dexamethasone 1589Nivolumab 1516Doxorubicin 1477Rituximab 1453Etoposide 1341Magnetic Resonance Spectroscopy 1261Irinotecan 1232Leucovorin 1212Cytarabine 1123Pemetrexed 1060Drug Therapy 1060fludarabine 1044Vincristine 956Specimen Handling 928Prednisone 924Cetuximab 919Lenalidomide 916Trastuzumab 897

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Ertapenem × Clear all
NCT04502095 2025-08-03

Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy

Roswell Park Cancer Institute

Phase 4 Completed
89 enrolled
Genitourinary

Urinary Bladder Neoplasms, Urinary Tract Infections

NCT03218800 2022-08-11

Ertapenem Administered Subcutaneously Versus Intravenously

Instituto Nacional de Cancer, Brazil

Phase 3 Terminated
30 enrolled

Urinary Tract Infections

NCT00535652 2017-02-10

Concentration of Ertapenem in Colorectal Tissue

University of Ulm

Phase 4 Completed
23 enrolled 5 charts
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Diverticulosis, Colonic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡